Displaying 1 - 1 of 1
| Active Ingredient | CASPOFUNGIN |
| Therapeutic Class | ECHINOCANDINS |
| Indications | Invasive aspergillosis in patients refractory to, or intolerant of, other therapy. Invasive candidiasis; empirical therapy for presumed fungal infections in febrile, neutropenic patients. |
| Caution | Diarrhoea, nausea, vomiting, flushing, headache, fever, tachycardia, venous complications around the infusion site. Possible histamine- mediated symptoms have included rash, facial swelling, pruritu More ... |
| Dose Range | Adult: 70mg as a loading dose on the first day, followed by 50mg daily given as a slow IV infusion over 1 hour. Children: 70 mg/m2 loading dose on the first day, followed by 50 mg/m2 once daily thereafter given by intravenous infusion over about 1 hou |
| Drug Interactions | |
| Pregnancy | Use is not advised unless necessary. |
| Breast Feeding |